查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
病理实验室市场规模、份额和趋势分析报告：按类型（医院）、实验室服务（一般生理学、临床实验室）、最终用户（医生推荐）、地区、细分市场预测 2022-2030 年
市场调查报告书
商品编码
1147608

病理实验室市场规模、份额和趋势分析报告：按类型（医院）、实验室服务（一般生理学、临床实验室）、最终用户（医生推荐）、地区、细分市场预测 2022-2030 年

Pathology Laboratories Market Size, Share & Trends Analysis Report By Type (Hospital-based), By Testing Services (General Physiological & Clinical Tests), By End User (Physician Referrals) By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 79 Pages | 商品交期: 2-10个工作天内

价格

病理实验室市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球病理实验室市场预计将达到 6122 亿美元。从 2022 年到 2030 年，该市场预计将以 7.86% 的复合年增长率增长。推动该行业的主要因素包括预期寿命延长、发展中国家医疗基础设施改善、医疗费用优惠以及定期检查需求增加。

此外，技术进步正在改变诊断的动态。创新技术使即时检测 (POCT) 设备变得便携，改进的取样技术使诊断服务更容易获得且更高效。通过通过质量、速度、效率和可扩展性来指导患者护理，预计会有几项进展来改变行业。医疗保健系统越来越强调病理学和诊断实验室成为更好的临床决策引擎的重要性，帮助医生更快、更准确地推理、诊断和监测患者。

COVID-19 大流行对病理学/诊断实验室提出了很高的要求，因为在大流行期间需要对 COVID-19 进行检测。 COVID-19感染的激增导致资金和测试的增加，推动了整个市场的增长。例如，美国 (NIH) 国立卫生研究院于 2020 年 9 月宣布，作为促进社区诊断计划的一部分，将扩大对一套新的 COVID-19 检测技术的製造支持，Maxim Biomedical 宣布 129.3 美元百万的赠款给 9 个组织，包括 Inc、MatMaCorp 和 MicroGEM International。

病理实验室市场报告要点

按类型划分，医院诊断实验室在 2021 年主导了市场。这是因为医院提供的先进测试是复杂诊断的最佳解决方案

由于成像技术的进步、事故的高发率和全球范围内的目标疾病，预计成像与放射学部分在预测期内将增长最快。

就最终用户而言，医生转诊在 2021 年主导了市场。由于监控个人健康和福祉的自我意识增强，预计普通客户和企业客户将实现有利增长

预计美国对心血管健康诊断的需求很高，因为它是美国最突出的疾病

预计在预测期内，欧洲对肿瘤检测的需求会很高。根据国际世界癌症研究基金会的数据，丹麦是世界上癌症患病率最高的国家。

最近，市场上出现了一些主要参与者之间的合作，希望为服务增加价值并扩大研究范围。例如，2022 年 7 月，Unilab 宣布与 Subtle Medical 建立合作伙伴关係，成为第一家采用该公司基于 AI 的 MRI 技术提供高质量、快速 MRI 的诊断公司。该解决方案将首先在瑞典推出。

内容

第 1 章调查方法及范围

  • 区域范围
  • 调查方法
    • 资讯采购
      • 购买的数据库
      • GVR 内部数据库
      • 次要资讯
      • 初步调查
      • 初步调查的详细资讯
  • 资讯或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
    • 商品流分析
    • 批量价格分析
  • 二级资讯列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场展望
  • 细分市场展望
  • 区域展望
  • 竞争考虑

第 3 章市场变量、趋势和范围

  • 市场动态
    • 市场促进因素分析
      • 改善新兴国家/地区的医疗保健基础设施
      • 对定期健康检查的需求不断增加
      • 用于诊断服务的礼服退款
    • 市场抑制因素分析
      • 高端分子诊断的价格实惠
      • 缺乏熟练劳动力
  • 商业环境分析工具
    • 波特的五力分析
      • 新进入者的威胁
      • 买家的议价能力
      • 竞争公司之间的敌对关係
      • 替代品的威胁
      • 供应商的议价能力
  • COVID-19 的影响
  • 监管框架和赎回方案

第 4 章病理实验室市场：类型分析

  • 2021 年和 2030 年按类型分类的病理实验室市场份额分析
  • 部门仪表板
  • 2017-2030 年类型市场规模及预测和趋势分析
    • 基于医院
    • 独立实验室
    • 诊断炼

第 5 章病理实验室市场：实验室服务分析

  • 2021 年和 2030 年病理实验室检测服务市场份额分析
  • 部门仪表板
  • 2017-2030 年测试服务市场规模及预测和趋势分析：
    • 一般生理和临床检查
    • 影像学和放射学
    • 奥术测试
    • COVID-19 测试

第 6 章病理实验室市场：最终用途分析

  • 病理实验室最终用途市场份额分析，2021 年和 2030 年
  • 部门仪表板
  • 2017-2030 年以下最终用途的市场规模和预测以及趋势分析
    • 医生介绍
    • 上门服务
    • 企业

第 7 章病理实验室市场：区域分析

  • 病理实验室区域市场份额分析，2021 年和 2030 年
  • 区域市场概况（市场规模，CAGR）
  • 2017-2030 年市场规模、预测和趋势分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 意大利
      • 西班牙
      • 2017-203 年西班牙病理实验室市场（十亿美元）
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第 8 章竞争分析

  • 主要市场进入者的近期趋势和影响分析
  • 竞争对手分类（主要创新者、市场领导者、初创企业）
  • 公司简介
    • Quest Diagnostics Incorporated
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Eurofins Scientific
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Laboratory Corporation of America Holdings
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Exact Sciences Laboratories LLC
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Spectra Laboratories
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • SYNLAB International GmbH
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Sonic Healthcare Limited
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • DR Lal Path Labs.
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Metropolis Healthcare
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Kingmed Diagnostics
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Healius Limited
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • BioReference
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Centro de Diagnosticos
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Falco Holdings
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Unilabs
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
  • 供应商情况
    • Major Deals &Strategic Alliances
    • 公司市场分析
Product Code: GVR-4-68039-987-6

Pathology Laboratories Market Growth & Trends:

The global pathology laboratories market is expected to reach USD 612.2 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.86% from 2022 to 2030. The major factors driving the industry include increasing life expectancy, the development of healthcare infrastructure in developing nations, favoring reimbursement, and rising demand for routine medical check-ups.

In addition, the advancement of technology is altering the dynamics of diagnosis. Innovative technologies have made Point of Care Testing(POCT) devices portable and improved sampling techniques, making diagnostic services more accessible and efficient. Several advancements are expected to transform the industry by steering patient care through quality, speed, efficiency, and scalability. The healthcare system is progressively emphasizing the importance of pathological & diagnostic labs in becoming a greater clinical decision-making engine, assisting physicians in making inferences and diagnosing as well as monitoring patients more quickly and accurately.

The COVID-19 pandemic has resulted in higher demand for pathology/diagnostic labs as the testing for COVID-19 was necessary during the pandemic. The rapid rise of COVID-19 infections has resulted in increased funding and testing, which has boosted the overall market growth. For instance, the (NIH) National Institutes of Health in the United States announced in September 2020 that it would grant USD 129.3 million in funding to nine organizations including, Maxim Biomedical Inc., MatMaCorp, MicroGEM International, & others, for scaling-up manufacturing assistance to a new set of COVID-19 testing technologies as component of its initiative to boost diagnostics in the region.

Pathology Laboratories Market Report Highlights:

  • Based on type, hospital-based diagnostic labs dominated the market during the year 2021. This can be attributed to the advanced tests available at hospitals, making them the only best solution for complex diagnosis
  • The imaging & radiology tests segment is expected to have the fastest growth during the forecast period owing to the advancement in imaging techniques & the high prevalence of accidents & target diseases worldwide
  • Based on the end use, physician referrals dominated the market in 2021. Walk-in and corporate clients are expected to witness lucrative growth due to increased self-awareness for monitoring health and wellness among individuals
  • U.S. is expected to have a high demand for the diagnosis of cardiovascular health as a result of the most prominent disease in the U.S.
  • Europe is expected to have a high demand for oncology testing during the forecast period. Denmark has the highest prevalence of cancer globally in terms of cancer prevalence as per the World Cancer Research Fund International
  • The market is witnessing multiple collaborations in recent times with the key players aiming at adding value to their services & expanding their research. For Instance, in July 2022, Unilabs announced a partnership with Subtle Medical, to be the first diagnostic company to adopt their AI-based MRI technology for high-quality & quick MRI. The solution will be first launched in Sweden.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Regional Scope
  • 1.2 Estimates and Forecast Timeline
  • 1.3 Research Methodology
    • 1.3.1 Information procurement
      • 1.3.1.1 Purchased database
      • 1.3.1.2 GVR'S internal database
      • 1.3.1.3 Secondary sources
      • 1.3.1.4 Primary research
      • 1.3.1.4.1 Details of the primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2
    • 1.9.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Regional Outlook
  • 2.4 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Improving healthcare infrastructure in developing countries
      • 3.1.1.2 Increasing demand for regular general health check-ups
      • 3.1.1.3 Gowning reimbursement for diagnostics services
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Affordability for high-end molecular diagnostics
      • 3.1.2.2 Shortage of skilled workforce.
  • 3.2 Business Environment Analysis Tools
    • 3.2.1 Porter's Five Forces Analysis
      • 3.2.1.1 Threat of new entrants
      • 3.2.1.2 Bargaining power of buyers
      • 3.2.1.3 Competitive rivalry
      • 3.2.1.4 Threat of substitutes
      • 3.2.1.5 Bargaining power of suppliers
  • 3.3 Impact of COVID-19
  • 3.4 Regulatory Framework & Reimbursement Scenario

Chapter 4 Pathology Laboratories Market: Type Analysis

  • 4.1 Pathology Laboratories by Type Market Share Analysis, 2021 & 2030
  • 4.2 Segment Dashboard
  • 4.3 Market Size and Forecasts and Trend Analysis, 2017 - 2030 for the Type
    • 4.3.1 Hospital Based
      • 4.3.1.1 Hospital-based market, 2017 - 2030 (USD Billion)
    • 4.3.2 Standalone Labs
      • 4.3.2.1 Standalone labs market, 2017 - 2030 (USD Billion)
    • 4.4.3 Diagnostic Chains
      • 4.4.3.1 Diagnostic chains market, 2017 - 2030 (USD Billion)

Chapter 5 Pathology Laboratories Market: Testing Services Analysis

  • 5.1 Pathology Laboratories Testing Services Market Share Analysis, 2021 & 2030
  • 5.2 Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the Testing Services:
    • 5.3.1 General Physiological & Clinical Tests
      • 5.3.1.1 General physiological & clinical tests market, 2017 - 2030 (USD Billion)
    • 5.3.2 Imaging & Radiology Tests
      • 5.3.2.1 Imaging & radiology tests market, 2017 - 2030 (USD Billion)
    • 5.3.3 Esoteric Tests
      • 5.3.3.1 Esoteric tests market, 2017 - 2030 (USD Billion)
    • 5.3.4 COVID-19 Tests
      • 5.3.4.1 COVID-19 tests market, 2017 - 2030 (USD Billion)

Chapter 6 Pathology Laboratories Market: End-use Analysis

  • 6.1 Pathology Laboratories End-use Market Share Analysis, 2021 and 2030
  • 6.2 Segment Dashboard
  • 6.3 Market Size and Forecasts and Trend Analysis, 2017-2030 for the Following End-Use
    • 6.3.1 Physician Referrals
      • 6.3.1.1 Physician referrals market, 2017 - 2030 (USD Billion)
    • 6.3.2 Walk-Ins
      • 6.3.2.1 Walk-Ins market, 2017 - 2030 (USD Billion)
    • 6.3.3 Corporate
      • 6.3.3.1 Corporate market, 2017 - 2030 (USD Billion)

Chapter 7 Pathology Laboratories Market: Regional Analysis

  • 7.1 Pathology Laboratories Regional Market Share Analysis, 2021 & 2030
  • 7.2 Regional Market Snapshot (Market Size, CAGR)
  • 7.3 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
    • 7.3.1 North America
      • 7.3.1.1 North America pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.1.2 U.S.
      • 7.3.1.2.1 U.S. pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.1.3 Canada
      • 7.3.1.3.1 Canada pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.2 Europe
      • 7.3.2.1 Europe pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.2 U.K.
      • 7.3.2.2.1 UK pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.3 Germany
      • 7.3.2.3.1 Germany pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.4 France
      • 7.3.2.4.1 France pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.5 Italy
      • 7.3.2.5.1 Italy pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.6 Spain
      • 7.3.2.6.1 Spain pathology laboratories market, 2017 - 203 (0USD Billion)
    • 7.3.3 Asia Pacific
      • 7.3.3.1 Asia Pacific pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.2 Japan
      • 7.3.3.2.1 Japan pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.3 China
      • 7.3.3.3.1 China pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.4 India
      • 7.3.3.4.1 India pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.5 South Korea
      • 7.3.3.5.1 South Korea pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.6 Australia
      • 7.3.3.6.1 Australia pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.4 Latin America
      • 7.3.4.1 Latin America pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.4.2 Brazil
      • 7.3.4.2.1 Brazil pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.4.3 Mexico
      • 7.3.4.3.1 Mexico pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.4.4 Argentina
      • 7.3.4.4.1 Argentina pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.5 Middle East and Africa
      • 7.3.5.1 MEA pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.5.2 South Africa
      • 7.3.5.2.1 South Africa pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.5.3 Saudi Arabia
      • 7.3.5.3.1 Saudi Arabia pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.5.4 UAE
      • 7.3.5.4.1 UAE pathology laboratories market, 2017 - 2030 (USD Billion)

Chapter 8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2 Competition Categorization (Key innovators, Market leaders, Emerging Players)
  • 8.3 Company Profiles
    • 8.3.1 Quest Diagnostics Incorporated
      • 8.3.1.1 Company overview
      • 8.3.1.2 Financial performance
      • 8.3.1.3 Service benchmarking
      • 8.3.1.4 Strategic initiatives
    • 8.3.2 Eurofins Scientific
      • 8.3.2.1 Company overview
      • 8.3.2.2 Financial performance
      • 8.3.2.3 Service benchmarking
      • 8.3.2.4 Strategic initiatives
    • 8.3.3 Laboratory Corporation of America Holdings
      • 8.3.3.1 Company overview
      • 8.3.3.2 Financial performance
      • 8.3.3.3 Service benchmarking
      • 8.3.3.4 Strategic initiatives
    • 8.3.4 Exact Sciences Laboratories LLC
      • 8.3.4.1 Company overview
      • 8.3.4.2 Financial performance
      • 8.3.4.3 Service benchmarking
      • 8.3.4.4 Strategic initiatives
    • 8.3.5 Spectra Laboratories
      • 8.3.5.1 Company overview
      • 8.3.5.2 Financial performance
      • 8.3.5.3 Service benchmarking
      • 8.3.5.4 Strategic initiatives
    • 8.3.6 SYNLAB International GmbH
      • 8.3.6.1 Company overview
      • 8.3.6.2 Financial performance
      • 8.3.6.2 Service benchmarking
      • 8.3.6.3 Strategic initiatives
    • 8.3.7 Sonic Healthcare Limited
      • 8.3.7.1 Company overview
      • 8.3.7.2 Financial performance
      • 8.3.7.2 Service benchmarking
      • 8.3.7.3 Strategic initiatives
    • 8.3.8 DR Lal Path Labs.
      • 8.3.8.1 Company overview
      • 8.3.8.2 Financial performance
      • 8.3.8.3 Service benchmarking
      • 8.3.8.4 Strategic initiatives
    • 8.3.9 Metropolis Healthcare
      • 8.3.9.1 Company overview
      • 8.3.8.2 Financial performance
      • 8.3.9.2 Service benchmarking
      • 8.3.9.4 Strategic initiatives
    • 8.3.10 Kingmed Diagnostics
      • 8.3.10.1 Company overview
      • 8.3.10.2 Financial performance
      • 8.3.10.2 Service benchmarking
      • 8.3.10.4 Strategic initiatives
    • 8.3.11 Healius Limited
      • 8.3.11.1 Company overview
      • 8.3.11.2 Financial performance
      • 8.3.11.2 Service benchmarking
      • 8.3.11.4 Strategic initiatives
    • 8.3.12 BioReference
      • 8.3.12.1 Company overview
      • 8.3.12.2 Financial performance
      • 8.3.12.2 Service benchmarking
      • 8.3.12.4 Strategic initiatives
    • 8.3.13 Centro de Diagnosticos
      • 8.3.13.1 Company overview
      • 8.3.13.2 Financial performance
      • 8.3.13.2 Service benchmarking
      • 8.3.13.4 Strategic initiatives
    • 8.3.14 Falco Holdings
      • 8.3.14.1 Company overview
      • 8.3.14.2 Financial performance
      • 8.3.14.2 Service benchmarking
      • 8.3.14.4 Strategic initiatives
    • 8.3.15 Unilabs
      • 8.3.15.1 Company overview
      • 8.3.15.2 Financial performance
      • 8.3.15.2 Service benchmarking
      • 8.3.15.4 Strategic initiatives
  • 8.4 Vendor Landscape
    • 8.4.1 Major Deals & Strategic Alliances
    • 8.4.1 Company Market Position Analysis

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 Global pathology laboratories market, by Region, 2017 - 2030 (USD Billion)
  • TABLE 4 Global pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 5 Global pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 6 Global pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 7 North America pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 8 North America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 9 North America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 10 North America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 11 U.S. pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 12 U.S. pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 13 U.S. pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 14 Canada pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 15 Canada pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 16 Canada pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 17 Europe pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 18 Europe pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 19 Europe pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 20 Europe pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 21 UK pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 22 UK pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 23 UK pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 24 Germany pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 25 Germany pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 26 Germany pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 27 France pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 28 France pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 29 France pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 30 Italy pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 31 Italy pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 32 Italy pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 33 Spain pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 34 Spain pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 35 Spain pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 36 Rest of Europe pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 37 Rest of Europe pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 38 Rest of Europe pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 39 Asia Pacific pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 40 Asia Pacific pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 41 Asia Pacific pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 42 Asia Pacific pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 43 China pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 44 China pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 45 China pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 46 Japan pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 47 Japan pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 48 Japan pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 49 India pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 50 India pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 51 India pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 52 South Korea pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 53 South Korea pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 54 South Korea pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 55 Australia pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 56 Australia pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 57 Australia pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 58 Rest of Asia Pacific pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 59 Rest of Asia Pacific pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 60 Rest of Asia Pacific pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 61 Latin America pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 62 Latin America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 63 Latin America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 64 Latin America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 65 Brazil pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 66 Brazil pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 67 Brazil pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 68 Mexico pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 69 Mexico pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 70 Mexico pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 71 Argentina pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 72 Argentina pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 73 Argentina pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 74 Rest of Latin America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 75 Rest of Latin America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 76 Rest of Latin America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 77 Middle East & Africa pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 78 Middle East & Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 79 Middle East & Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 80 Middle East & Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 81 South Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 82 South Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 83 South Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 84 Saudi Arabia pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 85 Saudi Arabia pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 86 Saudi Arabia pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 87 UAE pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 88 UAE pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 89 UAE pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 90 Rest of Middle East & Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 91 Rest of Middle East & Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 92 Rest of Middle East & Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market outlook, 2021 (USD Billion)
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Pathology laboratories market: Type movement analysis (USD Billion)
  • FIG. 13 Pathology laboratories market Type Segment Dashboard
  • FIG. 14 Hospital-Based market, 2017 - 2030 (USD Billion)
  • FIG. 15 Standalone labs market 2017 - 2030 (USD Billion)
  • FIG. 16 Diagnostic chains market 2017 - 2030 (USD Billion)
  • FIG. 17 Pathology laboratories market: Testing Services movement analysis (USD Billion)
  • FIG. 18 Pathology laboratories market: Testing services segment dashboard
  • FIG. 19 General physiological & clinical tests market, 2017 - 2030 (USD Billion)
  • FIG. 20 Imaging & radiology market, 2017 - 2030 (USD Billion)
  • FIG. 21 Esoteric tests market, 2017 - 2030 (USD Billion)
  • FIG. 22 COVID-19 tests market, 2017 - 2030 (USD Billion)
  • FIG. 23 Pathology laboratories market: End-use movement analysis (USD Billion)
  • FIG. 24 Pathology laboratories market: End-use segment dashboard
  • FIG. 25 Physician referrals market, 2017 - 2030 (USD Billion)
  • FIG. 26 Walk-ins market, 2017 - 2030 (USD Billion)
  • FIG. 27 Corporate market, 2017 - 2030 (USD Billion)
  • FIG. 28 Regional outlook, (USD Billion)
  • FIG. 29 Regional market place: Key takeaways
  • FIG. 30 North America pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 31 U.S. pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 32 Canada pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 33 Europe pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 34 UK. pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 35 Germany pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 36 France pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 37 Italy pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 38 Spain pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 39 Asia Pacific pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 40 China pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 41 Japan pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 42 India pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 43 South Korea pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 44 Australia pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 45 Latin America pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 46 Brazil pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 47 Mexico pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 48 Argentina pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 49 MEA pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 50 South Africa pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 51 Saudi Arabia pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 52 UAE pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 53 Recent developments & impact analysis, by key market participants
  • FIG. 54 Company categorization
  • FIG. 55 Company market position analysis